Overview of the pathogenesis and causes of glomerulonephritis in children
- Patrick Niaudet, MD
Patrick Niaudet, MD
- Section Editor — Pediatric Nephrology
- Professor of Pediatrics
- Hôpital Necker-Enfants Malades, Paris, France
Glomerulonephritis (GN) generally presents as a constellation of findings that include hematuria, proteinuria, edema, and often hypertension. GN is caused by a number of disorders that are all characterized by glomerular injury accompanied by inflammation. In some cases, GN may progress to renal failure.
The pathogenesis and etiology of glomerulonephritis in children will be reviewed here. The approach to evaluating a child with glomerulonephritis is discussed separately. (See "Evaluation of a child with glomerular disease".)
Although the pathogenesis is not fully understood, current evidence suggests that most cases of glomerulonephritis (GN) are due to an immunologic response to a variety of different etiologic agents. The immunologic response, in turn, activates a number of biological processes (eg, complement activation, leukocyte recruitment, and release of growth factors and cytokines) that result in glomerular inflammation and injury [1,2]. GN may be isolated to the kidney (primary glomerulonephritis) or be a component of a systemic disorder (secondary glomerulonephritis) (table 1).
The immunologic mechanisms involved in the pathogenesis of GN are briefly reviewed here and are discussed in greater detail separately. (See "Mechanisms of immune injury of the glomerulus".)
Immunologic damage — Humoral (also referred to T helper cell 2-regulated) immune response to a variety of inciting agents results in immunoglobulin deposition and complement activation within the glomeruli. In most of these disorders, immune complex deposition is an active process caused by in situ binding of antibodies to antigens localized within the glomeruli. The antigens may be structural glomeruli components, such as the Goodpasture antigen in the non-collagenous domain of the alpha-3 chain of type IV collagen in the glomerular basement membrane (GBM) .To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:
- Chadban SJ, Atkins RC. Glomerulonephritis. Lancet 2005; 365:1797.
- Couser WG. Pathogenesis of glomerulonephritis. Kidney Int Suppl 1993; 42:S19.
- Hellmark T, Burkhardt H, Wieslander J. Goodpasture disease. Characterization of a single conformational epitope as the target of pathogenic autoantibodies. J Biol Chem 1999; 274:25862.
- Wu J, Hicks J, Borillo J, et al. CD4(+) T cells specific to a glomerular basement membrane antigen mediate glomerulonephritis. J Clin Invest 2002; 109:517.
- Nangaku M. Complement regulatory proteins in glomerular diseases. Kidney Int 1998; 54:1419.
- Kilgore KS, Schmid E, Shanley TP, et al. Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation. Am J Pathol 1997; 150:2019.
- Hughes J, Nangaku M, Alpers CE, et al. C5b-9 membrane attack complex mediates endothelial cell apoptosis in experimental glomerulonephritis. Am J Physiol Renal Physiol 2000; 278:F747.
- Atkins RC, Nikolic-Paterson DJ, Song Q, Lan HY. Modulators of crescentic glomerulonephritis. J Am Soc Nephrol 1996; 7:2271.
- Rodriguez-Iturbe B. Postinfectious glomerulonephritis. Am J Kidney Dis 2000; 35:XLVI.
- Zhang Y, Shen Y, Feld LG, Stapleton FB. Changing pattern of glomerular disease at Beijing Children's Hospital. Clin Pediatr (Phila) 1994; 33:542.
- Sanjad S, Tolaymat A, Whitworth J, Levin S. Acute glomerulonephritis in children: a review of 153 cases. South Med J 1977; 70:1202.
- Immunologic damage
- Secondary processes
- ETIOLOGIC CLASSIFICATION
- Clinical presentation
- - Acute GN
- - Rapidly progressive GN
- - Recurrent macroscopic hematuria
- - Chronic GN
- - Light microscopy
- - Immunofluorescence microscopy
- - Electron microscopy
- SPECIFIC DISORDERS
- Primary GN
- Secondary GN
- INFORMATION FOR PATIENTS
- SUMMARY AND RECOMMENDATIONS